Longboard Pharmaceuticals (LBPH) Earnings Date, Estimates & Call Transcripts → The Hidden Tax Advantages of America’s #1 Inheritance Stock (From Stansberry Research) (Ad) Free LBPH Stock Alerts $19.08 +0.98 (+5.41%) (As of 06/11/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 2) -$0.42 Beat By $0.06 Consensus EPS (May. 2) -$0.48 Get Longboard Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for LBPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLBPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LBPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a year ago that Trump’s conviction was already a foregone conclusion. But his prediction on Biden was, if anything, more surprising.This shocking video reveals exactly how. Longboard Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.56)($0.37)($0.47)Q2 20243($0.55)($0.41)($0.47)Q3 20243($0.62)($0.39)($0.50)Q4 20243($0.66)($0.39)($0.53)FY 202412($2.39)($1.56)($1.98)Q1 20252($0.57)($0.47)($0.52)Q2 20252($0.59)($0.50)($0.55)Q3 20252($0.62)($0.55)($0.59)Q4 20252($0.64)($0.60)($0.62)FY 20258($2.42)($2.12)($2.27)LBPH Earnings Date and InformationLongboard Pharmaceuticals last posted its quarterly earnings data on May 2nd, 2024. The reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.48) by $0.06. Longboard Pharmaceuticals has generated ($2.24) earnings per share over the last year (($2.24) diluted earnings per share). Earnings for Longboard Pharmaceuticals are expected to decrease in the coming year, from ($1.85) to ($2.43) per share. Longboard Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Longboard Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/2/2024Q1 2024($0.48)($0.42)+$0.06($0.42)--3/12/2024Q4 2023($0.60)($0.62)($0.02)($0.62)--11/2/2023Q3 2023($0.72)($0.55)+$0.17($0.55)--8/3/2023Q2 2023($0.61)($0.65)($0.04)($0.65)--5/9/2023Q1 2023($0.59)($0.56)+$0.03($0.56)--3/2/2023Q4 2022($0.63)($0.66)($0.03)($0.66)-- Get the Latest News and Ratings for LBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($0.51)($0.68)($0.17)($0.68)--8/4/2022Q2 2022($0.54)($0.67)($0.13)($0.67)--5/5/2022Q1 2022($0.52)($0.56)($0.04)($0.56)--3/3/2022Q4 2021($0.41)($0.52)($0.11)($0.52)--11/4/2021Q3 2021($0.48)($0.38)+$0.10($0.38)--8/9/2021Q2 2021($0.67)($0.41)+$0.26($0.41)--5/10/2021Q1 2021-($0.84)($0.84)($0.84)-- Longboard Pharmaceuticals Earnings - Frequently Asked Questions When is Longboard Pharmaceuticals's earnings date? Longboard Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on LBPH's earnings history. Did Longboard Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Longboard Pharmaceuticals (NASDAQ:LBPH) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.48) by $0.06. Learn more on analysts' earnings estimate vs. LBPH's actual earnings. How much profit does Longboard Pharmaceuticals generate each year? Longboard Pharmaceuticals (NASDAQ:LBPH) has a recorded net income of -$54.42 million. LBPH has generated -$2.24 earnings per share over the last four quarters. What is Longboard Pharmaceuticals's EPS forecast for next year? Longboard Pharmaceuticals's earnings are expected to decrease from ($1.85) per share to ($2.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SCTL Earnings Date DYN Earnings Date MOR Earnings Date AGIO Earnings Date RNA Earnings Date MLTX Earnings Date ACAD Earnings Date GPCR Earnings Date JANX Earnings Date TGTX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:LBPH) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longboard Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.